Admin

History of Cannabis Prohibition and Scheduling

February 21, 2025 by Admin

Please join us for our next webinar, “History of Cannabis Prohibition and Scheduling”.

Dr. Russo will cover:

Cannabis prohibition in the USA, established under false pretenses in 1937, has been an abject failure as have all such efforts with other substances worldwide.
Cannabis was placed in Schedule I of the Controlled Substances Act in 1970 as a placeholder, and has remained there despite the recommendations of the Shafer Commission and various administrative law judges
Cannabis does not fit in the established schedules and should be de-scheduled, legalized, and regulated for medical use, and other uses similar to alcohol and tobacco, which are much more dangerous substances.

This webinar will take place Thursday, March 13th, 2025, 11am PST/ 2pm EST on Zoom. It is free to attend.

ALS Webinar

February 1, 2025 by Admin

Please join us for our next webinar, “Update on ALS: Amyotrophic Lateral Sclerosis, Cannabis, and Hope for the Future”.

The webinar will cover:

1) ALS is a terminal condition in which the motor neurons (nerves to the muscles) slowly deteriorate.
2) Despite decades of research, no breakthrough conventional treatments have emerged.
3) Various cannabis components target underlying pathology in ALS and offer the promise of palliatively treating its many symptoms.

This seminar is FREE to those who register via Zoom.

CBG Webinar

July 25, 2024 by Admin

This webinar discussed the July 2024 peer-reviewed publication “Acute effects of cannabigerol on anxiety, stress, and mood: a double blind, placebo controlled, crossover, field trial”, by Carrie Cuttler, Amanda Stueber, Ziva D. Cooper & Ethan Russo.

Dr. Russo, preeminent pharmacologist, neurologist and medical cannabis researcher, presented the findings of this important work. It is the first randomized placebo controlled clinical trail to investigate the effects of cannabigerol (CBG) on anxiety, mood, and stress and is a major step forward in demonstrating safety and efficacy of the molecule.

This webinar:

1) Reviewed the history and basic science of CBG.
2) Reviewed the recent Scientific Reports article by Cuttler et al. demonstrating anti-anxiety and anti-stress responses of CBG without impairment in a randomized controlled trial
3) Provided a greater understanding of the therapeutic benefits of CBG

The webinar is now available for purchase and download at: https://buycredo.mm411.com/

Limonene & THC: Support for Cannabis Synergy and the Entourage Effect

May 17, 2024 by Admin

Would you like to learn more about the Entourage Effect?

Preeminent medical cannabis researcher Dr. Ethan Russo presented background and results for the first research to demonstrate the Entourage Effect. This was an informative hour learning about how vaporized D-limonene reduces Delta-9 THC-induced anxiety in healthy adults.

The webinar addressed:
1) Historical review of limonene/citrus as an antidote to cannabis over-indulgence
2) The basic science of limonene effects on the brain

Dr. Russo will also provided background and review the outcomes of the recent peer-reviewed journal article: Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis.

This exciting research conducted at John Hopkins University School of Medicine and Colorado University’s (CU) Skaggs School of Pharmacy and Pharmaceutical Sciences, and the CU Department of Anesthesiology, is the first to scientifically demonstrate the Entourage Effect.

The webinar is now available for purchase and download at: https://buycredo.mm411.com/

Leading Global Provider of Digital Cannabis Education Teams Up with Renowned Medical Expert Dr. Ethan Russo

May 2, 2024 by Admin

MM411 Collaboration with Russo’s CreDO Science Will Deliver Accurate, Evidence-based Cannabis and Endocannabinoid system (ECS) Education

Initial, Foundational Offering Now Available Through MM411 with Expanded Courses Planned for September

Class Tailored to Medical Professionals, Patients, Caregivers, Advocates, and Industry Workers

[May 2, 2024] – Medical Marijuana 411 (MM411), the leading global provider of digital cannabis education, today announced a groundbreaking collaboration with CReDO Science, led by Dr. Ethan Russo, a board-certified neurologist and the world’s preeminent medical cannabis clinician and researcher, to deliver accurate, evidence-based cannabis and endocannabinoid system education. An initial foundational class developed by Dr. Russo, MM411 President Christine DeVol, and Nishi Whiteley, MS, Chief Operating Officer of CReDO Science, is now available in English, Spanish, and Japanese through MM411 and features 8 webinar modules totaling 11 hours, with an expanded, follow-up class planned for September.

“We are thrilled to join forces with CReDO Science to offer this unparalleled digital cannabis education platform,” said President DeVol. “By combining our expertise in digital education with Dr. Russo’s extensive research and clinical expertise, we are poised to greatly improve the quality of cannabis education available to all as we create a legacy of his decades of groundbreaking work.”

“Cannabis has immense therapeutic potential, but misinformation and stigma often cloud its true benefits and medical use,” said Dr. Russo. “Through this collaboration with MM411 we hope to empower healthcare professionals, patients, and advocates around the globe with accurate, science-backed knowledge to fully understand the risks and benefits of cannabis use. Together, we can transform the cannabis landscape.”

Through the collaboration, Dr. Russo is distilling decades of peer-reviewed scientific studies along with his 28 years of clinical cannabis experience to ensure students receive the most accurate and up-to-date information on cannabis and its potential medical applications in a format that is comprehensible to a wide-reaching audience of medical professionals, patients, caregivers, advocates, and industry workers. As part of the experience, Dr. Russo incorporates detailed citations throughout course materials, allowing students to understand from where his lessons are based and granting them further access to the tools they will need to dive deeper.

The initial course offering aims to demystify the mechanisms by which cannabis components interact with the human body. It will make understandable the science behind cannabis and the human endocannabinoid system. This will empower healthcare professionals to integrate cannabis in their practices, patients looking to understand the science behind their treatment, and industry professionals to better serve their customers. By helping learners to make informed decisions about its use, the program will contribute to the safety and efficacy of cannabis consumption worldwide.

For more information about the collaboration between MM411 and CReDO Science and to enroll in the digital cannabis education courses, visit here. Join us on this transformative journey toward a better-informed cannabis community.

Cannabis use is growing worldwide evidenced by The United Nations World Drug Report of 2023 which estimates 219 million people worldwide use cannabis. The US government report 2022 National Survey on Drug Use and Health estimates 59 million people 18 and older used cannabis in the year prior. But cannabis education has fallen behind. According to the journal article, Physicians-in-training are not prepared to prescribe medical marijuana by Evanoff et al, 89.5% of residents and fellows graduating from American medical schools felt they were not at all prepared to prescribe medical marijuana, 35.3% felt not at all prepared to answer questions, and 84.9% reported receiving no education in medical school or residency on medical marijuana. The report further outlined only 9% of medical school curriculums included content on medical cannabis.

About MM411:

MM411 https://medicalmarijuana411.com Founded in 2009, MM411 is the global leader in medical cannabis education. Thousands of medical professionals from 20 different countries have taken MM411 research-based cannabis courses. With cannabis education programs approved by more U.S. states than any other organization, MM411 offers medical cannabis certifications and aligns with government entities to develop certification programs for medical and industry professionals, U.S. state-required certifications for healthcare professionals, and cannabis consultants (budtenders). Certifications are focused on areas such as federal and state marijuana laws, science, endocannabinoid system, approved conditions, safe handling, dispensary customer service, how to use various product methods, and dosing.

About CReDO Science: CReDO Science https://credo-science.com is a private company that offers licensing of its innovations, provides clinical cannabis research consulting and formulation and product development consulting for wellness, medical, adult-use and pharmaceutical products.

###

Media Contact:
Freeman Klopott
Fklopott@marinopr.com

New Course Offering